Abstract
Adoptive cell therapy (ACT) of tumor infiltration lymphocytes (TIL) yields promising clinical results in metastatic melanoma patients, who failed standard treatments. Due to the fact that metastatic lung cancer has proven to be susceptible to immunotherapy and possesses a high mutation burden, which makes it responsive to T cell attack, we explored the feasibility of TIL ACT in non-small cell lung cancer (NSCLC) patients. Multiple TIL cultures were isolated from tumor specimens of five NSCLC patients undergoing thoracic surgery. We were able to successfully establish TIL cultures by various methods from all patients within an average of 14 days. Fifteen lung TIL cultures were further expanded to treatment levels under good manufacturing practice conditions and functionally and phenotypically characterized. Lung TIL expanded equally well as 103 melanoma TIL obtained from melanoma patients previously treated at our center, and had a similar phenotype regarding PD1, CD28, and 4-1BB expressions, but contained a higher percent of CD4 T cells. Lung carcinoma cell lines were established from three patients of which two possessed TIL cultures with specific in vitro anti-tumor reactivity. Here, we report the successful pre-clinical prod...Continue Reading
References
Jul 15, 1996·Cancer·G B RattoG Melioli
Apr 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark E DudleySteven A Rosenberg
Nov 10, 2009·The Journal of Surgical Research·Arman KilicMatthew J Schuchert
Jan 23, 2010·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Robert C DoebelePaul A Bunn
Feb 10, 2011·Journal of Immunotherapy·Orit ItzhakiMichal J Besser
May 17, 2011·The Journal of Surgical Research·Zachary D HorneMatthew J Schuchert
Mar 17, 2012·Journal of Immunotherapy·Jianjian JinSteven A Rosenberg
Sep 22, 2012·Journal of Immunotherapy·Shari Pilon-ThomasAmod A Sarnaik
Oct 4, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Laszlo G RadvanyiPatrick Hwu
May 7, 2013·Nature Medicine·Paul F RobbinsSteven A Rosenberg
May 8, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark E DudleySteven A Rosenberg
May 22, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michal J BesserJacob Schachter
Jun 19, 2013·Nature·Michael S LawrenceGad Getz
Oct 22, 2013·Nature Biotechnology·Christian S Hinrichs, Nicholas P Restifo
Jul 6, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yong-Chen LuPaul F Robbins
Jan 27, 2015·Current Opinion in Immunology·Daniel Sanghoon Shin, Antoni Ribas
Oct 31, 2015·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Marissa MayorPrasad S Adusumilli
Jan 9, 2016·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Mar 24, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rikke AndersenInge Marie Svane
May 25, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephanie L GoffSteven A Rosenberg
Jul 28, 2016·Reviews on Recent Clinical Trials·Anshu GiriAjeet Gajra
Oct 27, 2017·Frontiers in Immunology·Sivan Seliktar-OfirMichal J Besser
Citations
Mar 1, 2020·International Journal of Molecular Sciences·Linda Tran, Dan Theodorescu
May 19, 2020·Immunopharmacology and Immunotoxicology·Yipeng MaMingjun Wang
Nov 30, 2018·Frontiers in Immunology·Maryam DadarWanpen Chaicumpa
Nov 25, 2018·Virchows Archiv : an International Journal of Pathology·Maartje W RohaanJohn B A G Haanen
Jan 11, 2020·Frontiers in Immunology·Jin-Zhi LaiQiu-Yu Zhang
Sep 2, 2020·International Journal of Molecular Sciences·Rajeev DhuparAdam C Soloff
Sep 18, 2020·Cells·Lena GaissmaierPetros Christopoulos
Mar 13, 2019·Journal of Experimental & Clinical Cancer Research : CR·Linan FangLi Zhang
Nov 20, 2019·Oncoimmunology·Sharon YungerMichal J Besser
Oct 28, 2019·Oncoimmunology·Rosa De GrootMonika C Wolkers
May 31, 2020·Cancer Immunology, Immunotherapy : CII·Morten NielsenNiels Junker
Nov 3, 2020·Cancer Immunology, Immunotherapy : CII·Lata SinghSeema Kashyap
Nov 25, 2020·Journal for Immunotherapy of Cancer·Marie KroemerChristophe Borg
Sep 15, 2018·Therapeutic Advances in Respiratory Disease·Nicolas Villanueva, Lyudmila Bazhenova
Jan 19, 2021·Life Sciences·Xiaolan WenWen Zhang
Feb 5, 2021·Oncoimmunology·Saskia D van AstenMonika C Wolkers
Feb 22, 2021·Japanese Journal of Clinical Oncology·Eiji NakataToshifumi Ozaki
Mar 12, 2021·Journal for Immunotherapy of Cancer·Yi SunLu Yang
Jun 19, 2021·Frontiers in Immunology·Amrendra KumarAnna E Vilgelm
Aug 2, 2021·BMC Cancer·Wanjun YuSheng Xia
Aug 31, 2021·Journal of Immunology Research·Xiaoyun LiYuan Yang
Oct 6, 2021·Journal for Immunotherapy of Cancer·Anders Handrup KvernelandInge Marie Svane